CSCI
Price
$3.34
Change
-$0.03 (-0.89%)
Updated
Jun 27 closing price
Capitalization
10.4M
RNAC
Price
$10.68
Change
-$0.78 (-6.81%)
Updated
Jun 27 closing price
Capitalization
276.02M
Interact to see
Advertisement

CSCI vs RNAC

Header iconCSCI vs RNAC Comparison
Open Charts CSCI vs RNACBanner chart's image
COSCIENS Biopharma
Price$3.34
Change-$0.03 (-0.89%)
Volume$640
Capitalization10.4M
Cartesian Therapeutics
Price$10.68
Change-$0.78 (-6.81%)
Volume$300.63K
Capitalization276.02M
CSCI vs RNAC Comparison Chart in %
Loading...
CSCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CSCI vs. RNAC commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSCI is a Buy and RNAC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (CSCI: $3.34 vs. RNAC: $10.68)
Brand notoriety: CSCI and RNAC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CSCI: 20% vs. RNAC: 419%
Market capitalization -- CSCI: $10.4M vs. RNAC: $276.02M
CSCI [@Biotechnology] is valued at $10.4M. RNAC’s [@Biotechnology] market capitalization is $276.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSCI’s FA Score shows that 0 FA rating(s) are green whileRNAC’s FA Score has 0 green FA rating(s).

  • CSCI’s FA Score: 0 green, 5 red.
  • RNAC’s FA Score: 0 green, 5 red.
According to our system of comparison, RNAC is a better buy in the long-term than CSCI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSCI’s TA Score shows that 3 TA indicator(s) are bullish while RNAC’s TA Score has 5 bullish TA indicator(s).

  • CSCI’s TA Score: 3 bullish, 5 bearish.
  • RNAC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RNAC is a better buy in the short-term than CSCI.

Price Growth

CSCI (@Biotechnology) experienced а +1.21% price change this week, while RNAC (@Biotechnology) price change was +9.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNAC($276M) has a higher market cap than CSCI($10.4M). CSCI YTD gains are higher at: 20.578 vs. RNAC (-40.369). CSCI has higher annual earnings (EBITDA): -15.36M vs. RNAC (-83.55M). RNAC has more cash in the bank: 180M vs. CSCI (13.8M). CSCI has less debt than RNAC: CSCI (2.23M) vs RNAC (14.1M). RNAC has higher revenues than CSCI: RNAC (34.2M) vs CSCI (9.03M).
CSCIRNACCSCI / RNAC
Capitalization10.4M276M4%
EBITDA-15.36M-83.55M18%
Gain YTD20.578-40.369-51%
P/E RatioN/A2.00-
Revenue9.03M34.2M26%
Total Cash13.8M180M8%
Total Debt2.23M14.1M16%
FUNDAMENTALS RATINGS
CSCI vs RNAC: Fundamental Ratings
CSCI
RNAC
OUTLOOK RATING
1..100
768
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
99
Overvalued
PROFIT vs RISK RATING
1..100
75100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
5264
P/E GROWTH RATING
1..100
9745
SEASONALITY SCORE
1..100
25n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CSCI's Valuation (51) in the Biotechnology industry is somewhat better than the same rating for RNAC (99). This means that CSCI’s stock grew somewhat faster than RNAC’s over the last 12 months.

CSCI's Profit vs Risk Rating (75) in the Biotechnology industry is in the same range as RNAC (100). This means that CSCI’s stock grew similarly to RNAC’s over the last 12 months.

CSCI's SMR Rating (98) in the Biotechnology industry is in the same range as RNAC (100). This means that CSCI’s stock grew similarly to RNAC’s over the last 12 months.

CSCI's Price Growth Rating (52) in the Biotechnology industry is in the same range as RNAC (64). This means that CSCI’s stock grew similarly to RNAC’s over the last 12 months.

RNAC's P/E Growth Rating (45) in the Biotechnology industry is somewhat better than the same rating for CSCI (97). This means that RNAC’s stock grew somewhat faster than CSCI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CSCIRNAC
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 13 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
CSCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CUK24.770.96
+4.03%
Carnival PLC
ADXN9.000.19
+2.18%
Addex Therapeutics Ltd
MCY66.050.71
+1.09%
Mercury General Corp
CCAP14.48-0.08
-0.55%
Crescent Capital BDC
FATE1.04-0.06
-5.45%
Fate Therapeutics

CSCI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSCI has been closely correlated with NCNA. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if CSCI jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSCI
1D Price
Change %
CSCI100%
-0.89%
NCNA - CSCI
88%
Closely correlated
N/A
RNAC - CSCI
88%
Closely correlated
-6.81%
WINT - CSCI
87%
Closely correlated
+21.49%
BCDA - CSCI
81%
Closely correlated
-3.59%
NRXP - CSCI
79%
Closely correlated
-2.29%
More

RNAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAC has been closely correlated with WINT. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if RNAC jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAC
1D Price
Change %
RNAC100%
-6.81%
WINT - RNAC
94%
Closely correlated
+21.49%
NCNA - RNAC
92%
Closely correlated
N/A
NBY - RNAC
91%
Closely correlated
+0.97%
SNPX - RNAC
91%
Closely correlated
+23.37%
SNGX - RNAC
89%
Closely correlated
-0.73%
More